Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

←Back to companies

ARV · NZX

Arvida Group (ARV)

Healthcare / Retirement living•Covered: HY26 - FY26•2 published briefings

Arvida Group is an NZX-listed healthcare / retirement living company with HY26 - FY26 of published result briefings.

Latest briefing

FY26 · Released 28 May 2026

Operating cash flow fell 33% as OCF/EBITDA dropped to 81% on lower ORA receipts

Underlying EBITDA rose 10% to $133m but operating cash inflows dropped $53m year-on-year, creating a material gap between reported earnings

Sections⌄
  1. Snapshot
  2. Chat
  3. Longitudinal View
  4. Follow-through
  5. Archive
  6. Related Insights
  1. Snapshot
  2. Chat
  3. Longitudinal View
  4. Follow-through
  5. Archive
  6. Related Insights

Snapshot

Latest metrics

FY26, released 28 May 2026

← Swipe to view more
ARV latest metrics
MetricValueChange
Revenue$262.7m—
EBITDA$133m—
NPAT$97.3m—
Operating cash flow$107.8m—
OCF / EBITDA %81.0%—
Net debt$1.1b—
Net debt / EBITDA8.16x—
ROE %5.8%—
PBT$96.3m—
FCF pre-lease$98.6m—

Source: latest published briefing (FY26, released 28 May 2026). Change compares against the prior equivalent period: not available for this company.

Chat

Ask about ARV

Ask follow-up questions about Arvida Group's latest result and company history.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about ARV

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Longitudinal view

Performance over time

The latest period is shown first.

← Swipe to view more
ARV metric history
MetricFY2612 MONTHS28 May 2026HY266 MONTHS28 November 2025Trend
Revenue$262.7m$131.9m
Chart
Revenue growth %3.6%5.1%
Chart
EBITDA$133m$43.7m
Chart
EBITDA margin %50.6%33.1%
Chart
PBT$96.3m-$8m
Chart
PBT growth %6.3%—
—
NPAT$97.3m-$8.2m
Chart
NPAT growth %-3.5%—
—
Operating cash flow$107.8m$44.7m
Chart
OCF / EBITDA %81.0%102.3%
Chart
FCF pre-lease$98.6m$40.8m
Chart
ROE %5.8%-0.5%
Chart
Net debt$1.1b$1b
Chart
Net debt / EBITDA8.16x23.46x
Chart
Debtor days2026
Chart
Total assets$5b$4.7b
Chart

Reference: annolyse.ai/companies/arv

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

↗
Loading chart...

The setup & the reality

HY26 → FY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Current result now available

FY26 · Released 28 May 2026

Operating cash flow fell 33% as OCF/EBITDA dropped to 81% on lower ORA receipts

Underlying EBITDA rose 10% to $133m but operating cash inflows dropped $53m year-on-year, creating a material gap between reported earnings

Read latest briefing→

Historical setup

What HY26 said to watch

From Operating cash flow fell 44% as gross borrowings climbed to $1.0bn

No forward guidance or stated targets are supplied in this release. The FY25 shape shows H1 represented 49.5% of full-year revenue but only 43.7% of full-year Operating EBITDA — second-half weighted, with implied H2 FY25 EBITDA of $56.9m versus $44.1m in H1.

If the FY25 cadence repeats, full-year Operating EBITDA could again approach $100m. But reported NPAT is unlikely to benefit from a repeat of HY25's $72.9m fair value tailwind given the "subdued" property market commentary, so the reported earnings shape and the operating earnings shape will likely diverge again at year-end.

Open questions

Open questions from HY26

  • What drove the $34.8m drop in operating cash flow given EBITDA was flat — ORA settlement timing, refundable obligations, or other working-capital items?
  • How does management assess covenant headroom and refinancing risk on the $1.0bn gross debt stack now that Arvida reports as a debt-only issuer?
  • What fair value movement on investment property was recognised this half, and which valuation assumptions changed against the subdued market backdrop?
  • Will the H2-weighted EBITDA pattern from FY25 repeat, and what resale volume and pricing assumptions underpin that?
  • How does capital allocation change under the debt-only structure, particularly capex pacing and any internal return hurdles?

This briefing cannot assess covenant headroom, refinancing terms, or the specific fair value movement on investment property without those disclosures.

Archive

Briefing archive

Every published Annolyse briefing for this company appears here in reverse chronological order.

FY26 · Released 28 May 2026

Operating cash flow fell 33% as OCF/EBITDA dropped to 81% on lower ORA receipts

Underlying EBITDA rose 10% to $133m but operating cash inflows dropped $53m year-on-year, creating a material gap between reported earnings

Read briefing→

HY26 · Released 28 November 2025

Operating cash flow fell 44% as gross borrowings climbed to $1.0bn

Operating EBITDA was nearly flat but operating cash flow fell 44% and gross borrowings rose 34% to $1.0bn against a subdued property market.

Read briefing→

Related insights

Compare this company

The latest ARV metrics also appear in these cross-company views.

Insight

Cash conversion quality

This result converted 81.0% of EBITDA to operating cash flow.

Open insight→

Insight

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 9.8pp, with a distortion flag in the result.

Open insight→

Insight

Leverage and balance-sheet risk

Net debt / EBITDA is 8.16x for this result.

Open insight→

Insight

Revenue growth context

Revenue growth was 3.6% for this reporting period.

Open insight→

Get notified when ARV publishes

Get the next Arvida Group result briefing and five-year history updates by email.